Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. Molecular Formula: C24H24F3N5O5S3 Solubility: DMSO (
Molecular Weight:
615.67
Form:
Supplied as a White Solid
CAS Number:
[1195768-06-9]
* VAT and and shipping costs not included. Errors and price changes excepted